H-1B filings

Does CRISPR Therapeutics, Inc. sponsor H-1B?

Yes, according to public filings. CRISPR Therapeutics, Inc. filed 57 H-1B labor condition applications in fiscal years 2024-2026, including 12 in fiscal year 2026.

USCIS approved 39 H-1B petitions for this employer in fiscal years 2024-2026.

This page uses public government filings. A filing does not guarantee that the employer will sponsor you. This information is not legal advice.

Status on October 22, 2026: USCIS does not collect the $100,000 payment on new H-1B petitions for workers outside the U.S. while court orders stand. Appeals are pending, so this can change. USCIS H-1B FAQ

Labor condition applications by fiscal year

Fiscal yearFiledCertifiedWorkers
2026121212
2025181818
2024272424

An employer files a labor condition application with the Department of Labor before it files an H-1B petition. A certified application is not an approved visa. The U.S. fiscal year runs from October 1 to September 30.

USCIS decisions on H-1B petitions by fiscal year

Fiscal yearNew: approvedNew: deniedContinuing: approvedContinuing: denied
202610122
20254050
202420151

New petitions are for first H-1B employment. Continuing petitions are for extensions and for workers who change employers.

Typical roles and wage ranges

Job titleApplicationsWage range per yearMedian
Senior Research Associate11$100,000 - $117,915$103,770
Research Associate II5$85,038 - $95,862$92,000
Principal Research Associate4$116,936 - $123,838$120,000
Senior Research Associate, Analytical Development4$105,315 - $107,174$105,844
Scientist II2$144,472 - $145,000$145,000
Senior Quality Control Stability Specialist2$113,000 - $115,000$115,000
Manager, QA Operations2$120,000 - $128,500$128,500
Senior Research Associate, Translational Biology1$102,000 - $102,000$102,000
Senior Medical Director, Pharmacovigilance1$320,000 - $320,000$320,000
Associate Clinical Trial Manager1$124,919 - $124,919$124,919

Wages are the rates the employer stated in its applications. Actual pay can differ.

Top locations

Sources

Data release 2026q3, built on October 23, 2026.